/Companies

IDRx

3 known investors

Find your way into IDRx

Each arrow is one introduction. Sign up to fill in the first one.

297 people can intro you to Tim

Ask Manish Bhandari to introduce you to Tim Clackson

You →Manish · together at PanTher Therapeutics →Tim

Sign up to find every way you can get introduced to IDRx

  • Your email: who you already know at IDRx, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the IDRx team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

IDRx discovers, develops and delivers medicines and vaccines focused on cancer, HIV, respiratory diseases, and infectious diseases. The company aims to positively impact the health of 2.5 billion people by the end of the decade.

Founders & leadership

TCTim Clackson
Tim ClacksonA biotech executive whose leadership roles include President and CEO of Theseus Pharmaceuticals and President and Chief Technology Officer at Xilio Therapeutics. He has served on the boards of Elevation Oncology, Forma Therapeutics, MassBio, Kesmalea Therapeutics, and PanTher Therapeutics.

Investors · 3

Funding

SEC filings, press & company announcements

$120M disclosed across 1 of 4 rounds · 2022–2024

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does IDRx do?
IDRx discovers, develops and delivers medicines and vaccines focused on cancer, HIV, respiratory diseases, and infectious diseases. The company aims to positively impact the health of 2.5 billion people by the end of the decade.
Who are IDRx's investors?
IDRx's investors include Andreessen Horowitz, Nextech Invest, RA Capital.
How much funding has IDRx raised?
IDRx has disclosed $120M raised across 1 of its 4 known rounds.